DNA mikročipy (microarrays) v diagnostice folikulárního lymfomu: cesta k terapii "šité na míru" nebo slepá ulička?

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English DNA microchips (microarrays) in follicular lymphoma diagnostics: the pathway to "tailor-made therapy" or to impasse?
Authors

JANÍKOVÁ Andrea STAŇO KOZUBÍK Kateřina TICHÝ Boris MAYER Jiří KRÁL Zdeněk MICHALKA Jozef VÁŠOVÁ Ingrid POSPÍŠILOVÁ Šárka

Year of publication 2008
Type Article in Periodical
Magazine / Source Transfuze a hematologie dnes
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords folicullar lymphoma; diagnosis; prognosis; gene expression profiling; DNA microarrays
Description Follicular lymphoma (FL), an indolent B-lymphoproliferative disorder, is characterized by a long median survival of 8 to 10 years. Transformation to more aggressive lymphoma with poor prognosis occurs in 25-60% of patients with FL. Up to now; FL is considered to be an incurable disease with unpredictable individual course. Translocation t(14;18), the traditional genetic hallmark of FL, is of limited clinical improtance only. Prognostic and laboratory parametrs actually used have not been successful in individual stratification of FL patients as well. DNA microarrays enables analyses of the genomic expression program providing new insights into molecular pathogenesis of tumours. Gene expression profiling can reveal morphologically indistinguishable subgroups with different clinical behaviour in the frame of single disease, new important genes or prognosis based on molecular features.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info